Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 9,268 | 17,958 | 13,908 | 14,769 | 8,150 |
| Operating Income | -9,268 | -17,958 | -13,908 | -14,769 | -8,150 |
| Interest Expense | 1,753 | 1,693 | 1,809 | 1,832 | 1,834 |
| Other Income | 5,819 | 4,520 | 5,685 | -9,626 | -613 |
| Pre-tax Income | -5,202 | -15,131 | -10,032 | -26,227 | -10,597 |
| Income Tax | -19 | -60 | -39 | -8 | -31 |
| Net Income Continuous | -5,183 | -15,071 | -9,993 | -26,219 | -10,566 |
| Net Income | $-5,183 | $-15,071 | $-9,993 | $-26,219 | $-10,566 |
| EPS Basic Total Ops | 3.36 | -15.04 | -10.40 | -28.32 | -11.68 |
| EPS Basic Continuous Ops | 3.45 | -15.04 | -10.44 | -28.36 | -11.53 |
| EPS Diluted Total Ops | 7.52 | -15.04 | -14.56 | -28.32 | -11.68 |
| EPS Diluted Continuous Ops | 2.67 | -15.04 | -9.66 | -28.36 | -11.53 |
| EBITDA(a) | $-8,677 | $-17,553 | $-13,435 | $-14,296 | $-7,675 |